Clinical management of peripheral arterial disease in chronic kidney disease—a comprehensive review from the European Renal Association CKD-MBD Working Group
Open Access
- 7 April 2025
- journal article
- Published by Oxford University Press (OUP) in Clinical Kidney Journal
- Vol. 18 (5)
Abstract
Peripheral artery disease (PAD) is a common and serious complication in people with chronic kidney disease (CKD) and end-stage kidney disease, occurring four to six times more frequently than in the general population. PAD is characterized by atherosclerotic narrowing or occlusion of peripheral arteries, leads to lower limb ischaemia, and is associated with increased morbidity and mortality. People with CKD and PAD are at higher risk for cardiovascular events and presence of chronic limb-threatening ischaemia further doubles mortality risk in this population. The pathophysiology of PAD in CKD is multifactorial, involving endothelial dysfunction, inflammation, oxidative stress and disordered mineral metabolism; these are key CKD features that exacerbate vascular disease. Traditional risk factors, such as diabetes, hypertension, dyslipidaemia and smoking, also contribute to the development of PAD. Mineral imbalances and metabolic disturbances, seen in CKD-related mineral bone disorders (MBD), including vitamin D deficiency, are an emerging interest area in the development of PAD. Diagnosing PAD in CKD is challenging due to symptom overlap; non-invasive and inexpensive diagnostic tools such as ankle brachial index and toe brachial index offer potential for routine screening. Management of PAD is largely based on guidelines for the general population overlooking the unique differences in CKD patients. A multifaceted approach is fundamental (including lifestyle modifications, pharmacotherapy and, in some cases, revascularization procedures). This comprehensive review (i) outlines the epidemiology, aetiology and pathophysiology of PAD in CKD, (ii) discusses the role of CKD-MBD in PAD and (iii) highlights ongoing studies and the future therapeutic landscape.Keywords
This publication has 165 references indexed in Scilit:
- Smoking Cessation Improves Outcomes in Patients With Peripheral Artery DiseaseJAMA Cardiology, 2022
- Prevalence and Disease Burden of Chronic Kidney Disease2019
- Risk of Cardiovascular Disease and Mortality in Young Adults With End-stage Renal DiseaseJAMA Cardiology, 2019
- Hypoalbuminemia: Pathogenesis and Clinical SignificanceJournal of Parenteral and Enteral Nutrition, 2018
- Exercise for intermittent claudicationCochrane Database of Systematic Reviews, 2017
- Systematic review of the efficacy of cilostazol, naftidrofuryl oxalate and pentoxifylline for the treatment of intermittent claudicationBritish Journal of Surgery, 2012
- Coronary, Peripheral and Cerebrovascular Disease: a Complex RelationshipHerz, 2008
- Relations of Serum Phosphorus and Calcium Levels to the Incidence of Cardiovascular Disease in the CommunityArchives of internal medicine (1960), 2007
- Peripheral Arterial Disease Detection, Awareness, and Treatment in Primary CareJAMA, 2001
- A New Pharmacological Treatment for Intermittent Claudication:Archives of internal medicine (1960), 1999